# Uncovering molecular effectors of mammalian aging

> **NIH NIH DP1** · HARVARD UNIVERSITY · 2021 · $1,183,000

## Abstract

Project Summary
 Aging is the single largest risk factor for most chronic degenerative diseases, including cardiovascular,
musculoskeletal and neurodegenerative dysfunctions, and age-associated diseases now represent the most
rapidly growing unmet medical need in our society. Yet, while certain “hallmarks of aging” have been defined,
the critical molecular mediators that drive (and oppose) mammalian aging phenotypes have yet to be
systematically explored, due in part to the technological challenges of applying classic functional genetic
approaches, which require the laborious generation and aging(!) of complex gene-specific germline and
conditional knockout alleles, to studies of aging physiology. As this substantial knowledge gap presents a
significant impediment to developing new therapies for human aging pathologies, we aim in this project to
establish a new, more facile approach to interrogating the genes and pathways that regulate mammalian organ
function and repair throughout life.
 Our approach will take advantage of a unique in vivo genome editing system through which we can
experimentally induce programmable mutations into the genomes of stem cells in the blood and skeletal
muscle in intact animals, without the requirement for stem cell isolation and transplantation. By targeting
endogenous stem cells, we allow for the maintenance and propagation of these mutations but circumvent the
need to remove these cells their native biological niche, which can induce cellular stress and alter stem cell
behavior by exposure to non-physiological ex vivo conditions. We also enable rapid testing of potential
combinatorial gene effects, in multiple genetic backgrounds and in mice of various ages. Thus, our approach
provides a more powerful, and higher throughput, view into the molecular effectors of organismal aging, which
will allow us to test previously unapproachable hypotheses regarding the impact of somatic mutagenic events
in aging organ systems and to identify novel regulators that may drive the precocious onset of, or mediate
protection from, degenerative phenotypes across organ systems.
 Taken together, our work will yield new platform technologies for interrogating mammalian gene functions
in vivo, new insights into fundamental mechanisms of aging physiology and regenerative biology, and new and
potentially broadly useful methods for effecting genetic therapies in situ.

## Key facts

- **NIH application ID:** 10213650
- **Project number:** 5DP1AG063419-04
- **Recipient organization:** HARVARD UNIVERSITY
- **Principal Investigator:** AMY JO WAGERS
- **Activity code:** DP1 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2021
- **Award amount:** $1,183,000
- **Award type:** 5
- **Project period:** 2018-09-30 → 2023-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10213650

## Citation

> US National Institutes of Health, RePORTER application 10213650, Uncovering molecular effectors of mammalian aging (5DP1AG063419-04). Retrieved via AI Analytics 2026-05-23 from https://api.ai-analytics.org/grant/nih/10213650. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*